Indication
B-myeloid
1 clinical trial
6 products
2 drugs
Clinical trial
A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids for Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute LeukemiaStatus: Completed, Estimated PCD: 2023-02-21
Product
ClofarabineProduct
CytarabineProduct
DexamethasoneProduct
IdarubicinDrug
VarlilumabProduct
SorafenibDrug
VincristineProduct
Vincristine